HCC-Related lncRNAs: Roles and Mechanisms
International Journal of Molecular Sciences · 02.01.2024 · 25 (1) · 597
DOI: 10.3390/ijms25010597 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 02.01.2024. Verfasst von Mimansha Shah und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, VA 23298, USA. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, RNA, Long Noncoding, Liver Neoplasms. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 213 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) presents a significant global health threat, particularly in regions endemic to hepatitis B and C viruses, and because of the ongoing pandemic of obesity causing metabolic-dysfunction-related fatty liver disease (MAFLD), a precursor to HCC. The molecular intricacies of HCC, genetic and epigenetic alterations, and dysregulated signaling pathways facilitate personalized treatment strategies based on molecular profiling. Epigenetic regulation, encompassing DNA methyltion, histone modifications, and noncoding RNAs, functions as a critical layer influencing HCC development. Long noncoding RNAs (lncRNAs) are spotlighted for their diverse roles in gene regulation and their potential as diagnostic and therapeutic tools in cancer. In this review, we explore the pivotal role of lncRNAs in HCC, including MAFLD and viral hepatitis, the most prevalent risk factors for hepatocarcinogenesis. The dysregulation of lncRNAs is implicated in HCC progression by modulating chromatin regulation and transcription, sponging miRNAs, and influencing structural functions. The ongoing studies on lncRNAs contribute to a deeper comprehension of HCC pathogenesis and offer promising routes for precision medicine, highlighting the utility of lncRNAs as early biomarkers, prognostic indicators, and therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, VA 23298, USA.
- Department of Human and Molecular Genetics, Massey Comprehensive Cancer Center, and VCU Institute of Molecular Medicine (VIMM), Virginia Commonwealth University, Richmond, VA 23298, USA.
ORCID-Profile: Devanand Sarkar
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Shah, M., & Sarkar, D. (2024). HCC-Related lncRNAs: Roles and Mechanisms. International Journal of Molecular Sciences, 25(1), 597. https://doi.org/10.3390/ijms25010597
Vancouver
Shah M, Sarkar D. HCC-Related lncRNAs: Roles and Mechanisms. International Journal of Molecular Sciences. 2024;25(1):597. doi:10.3390/ijms25010597
BibTeX
@article{Shah2024,
author = {Shah, Mimansha and Sarkar, Devanand},
title = {HCC-Related lncRNAs: Roles and Mechanisms},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {1},
pages = {597},
doi = {10.3390/ijms25010597}
}
EUVIMED